Myriad Genetics, Inc.MYGNNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-26.1%
5Y CAGR-23.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-26.1%/yr
vs -7.7%/yr prior
5Y CAGR
-23.5%/yr
Consistent
Acceleration
-18.4pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.70 | -53.1% |
| 2024 | 1.48 | -29.5% |
| 2023 | 2.10 | +22.1% |
| 2022 | 1.72 | -44.5% |
| 2021 | 3.11 | +17.1% |
| 2020 | 2.65 | +101.0% |
| 2019 | 1.32 | -44.4% |
| 2018 | 2.37 | -29.3% |
| 2017 | 3.36 | +46.7% |
| 2016 | 2.29 | - |